Syncell

Watertown, United States

Syncell is a proteomics technology company enabling in situ protein drug target discovery.

$15.0M raised

Dec 2024

Series A

Top Investors

Taiwania Capital Management CorporationDarwin Venture Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Syncell raised?

Syncell has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.

Who are Syncell's investors?

Syncell's investors include Taiwania Capital Management Corporation, Darwin Venture Management.

Where is Syncell headquartered?

Syncell is headquartered in Watertown, United States.

What does Syncell do?

Syncell is a proteomics technology company enabling in situ protein drug target discovery.

What stage is Syncell at?

Syncell is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 11, 2024.

MLA

"Syncell — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/syncell. Accessed June 17, 2026.

APA

VCBacked. (2024). Syncell — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/syncell

Wikipedia (cite web)

{{cite web |title=Syncell — Funding & Investors |url=https://www.vcbacked.co/company/syncell |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 11, 2024.